155 related articles for article (PubMed ID: 17088032)
1. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
Nagai K; Nagasawa K; Kihara Y; Okuda H; Fujimoto S
Int J Pharm; 2007 Mar; 333(1-2):56-61. PubMed ID: 17088032
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
3. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells.
Robillard KR; Bone DB; Hammond JR
Microvasc Res; 2008 Apr; 75(3):351-7. PubMed ID: 18048066
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
Bone DB; Hammond JR
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel Na+-dependent nucleobase transport systems at the blood-testis barrier.
Kato R; Maeda T; Akaike T; Tamai I
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E968-75. PubMed ID: 16368787
[TBL] [Abstract][Full Text] [Related]
6. Mouse equilibrative nucleoside transporter 2 (mENT2) transports nucleosides and purine nucleobases differing from human and rat ENT2.
Nagai K; Nagasawa K; Kyotani Y; Hifumi N; Fujimoto S
Biol Pharm Bull; 2007 May; 30(5):979-81. PubMed ID: 17473446
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs.
Mori S; Ohtsuki S; Takanaga H; Kikkawa T; Kang YS; Terasaki T
J Neurochem; 2004 Aug; 90(4):931-41. PubMed ID: 15287899
[TBL] [Abstract][Full Text] [Related]
8. The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
Biochem Biophys Res Commun; 2011 Jul; 411(1):156-61. PubMed ID: 21723252
[TBL] [Abstract][Full Text] [Related]
9. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons.
Nagasawa K; Kawasaki F; Tanaka A; Nagai K; Fujimoto S
Glia; 2007 Nov; 55(14):1397-404. PubMed ID: 17674371
[TBL] [Abstract][Full Text] [Related]
10. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.
Yao SY; Ng AM; Vickers MF; Sundaram M; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2002 Jul; 277(28):24938-48. PubMed ID: 12006583
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.
Markovic I; Segal M; Djuricic B; Redzic Z
Exp Physiol; 2008 Mar; 93(3):325-33. PubMed ID: 18039975
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
13. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside transporter expression and function in cultured mouse astrocytes.
Peng L; Huang R; Yu AC; Fung KY; Rathbone MP; Hertz L
Glia; 2005 Oct; 52(1):25-35. PubMed ID: 15892125
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
Owen RP; Lagpacan LL; Taylor TR; De La Cruz M; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
Drug Metab Dispos; 2006 Jan; 34(1):12-5. PubMed ID: 16214850
[TBL] [Abstract][Full Text] [Related]
16. Equilibrative Nucleoside Transporter 2: Properties and Physiological Roles.
Naes SM; Ab-Rahim S; Mazlan M; Abdul Rahman A
Biomed Res Int; 2020; 2020():5197626. PubMed ID: 33344638
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
18. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
19. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).
Yao SY; Ng AM; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2011 Sep; 286(37):32552-62. PubMed ID: 21795683
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
